# Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China

Study · id `cardio:ct-nct02378350` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02378350](<https://clinicaltrials.gov/study/NCT02378350>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02378350

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 668 participants.

## Technical summary

Registry record NCT02378350. Randomized; no masking; primary purpose treatment. Start 2014-03-26 (actual); primary completion 2017-09-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 668 participants (enrolled count; ClinicalTrials.gov record NCT02378350, source copy `cardio:ctgov-nct02378350-2025-03-13`, retrieved 2026-10-26)
- Started: 2014-03-26 (actual) (ClinicalTrials.gov record NCT02378350, source copy `cardio:ctgov-nct02378350-2025-03-13`, retrieved 2026-10-26)
- Primary completion: 2017-09-18 (actual) (ClinicalTrials.gov record NCT02378350, source copy `cardio:ctgov-nct02378350-2025-03-13`, retrieved 2026-10-26)
- Completion: 2017-09-18 (actual) (ClinicalTrials.gov record NCT02378350, source copy `cardio:ctgov-nct02378350-2025-03-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02378350, source copy `cardio:ctgov-nct02378350-2025-03-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02378350-2025-03-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China
- Condition: End Stage Renal Disease
- Intervention (Device): Hemodialysis treatment (no specific device is defined)
- Intervention (Drug): Peritoneal Dialysis treatment (no specific drug is defined)
- Lead sponsor: Vantive Health LLC
- Lead sponsor class: INDUSTRY
- Collaborator: Baxter Healthcare Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Vantive Health LLC (`cardio:org-vantive-health-llc`)
- Registry lists this organization as a collaborator: Baxter Healthcare Corporation (`cardio:org-baxter-healthcare-corporation`)

## Provenance

Content hash: 4199f4b9d8498abc42293a82bb3520c31e8ff9c2d831f354f1f3046ce94ee940
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
